These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Generation and characterization of six single VP4 gene substitution reassortant rotavirus vaccine candidates: each bears a single human rotavirus VP4 gene encoding P serotype 1A[8] or 1B[4] and the remaining 10 genes of rhesus monkey rotavirus MMU18006 or bovine rotavirus UK. Hoshino Y; Jones RW; Chanock RM; Kapikian AZ Vaccine; 2002 Oct; 20(29-30):3576-84. PubMed ID: 12297404 [TBL] [Abstract][Full Text] [Related]
5. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children. Kapikian AZ; Flores J; Hoshino Y; Midthun K; Gorziglia M; Green KY; Chanock RM; Potash L; Sears SD; Clements ML Rev Infect Dis; 1989; 11 Suppl 3():S539-46. PubMed ID: 2548276 [TBL] [Abstract][Full Text] [Related]
6. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity. Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741 [TBL] [Abstract][Full Text] [Related]
7. Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses. Jin Q; Ward RL; Knowlton DR; Gabbay YB; Linhares AC; Rappaport R; Woods PA; Glass RI; Gentsch JR Arch Virol; 1996; 141(11):2057-76. PubMed ID: 8973523 [TBL] [Abstract][Full Text] [Related]
8. Development of candidate rotavirus vaccines. Bishop RF Vaccine; 1993; 11(2):247-54. PubMed ID: 8382418 [TBL] [Abstract][Full Text] [Related]
9. Sequential administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children. Kobayashi M; Araki K; Thompson J; Tollefson SJ; Wright PF J Infect Dis; 1993 Mar; 167(3):748-52. PubMed ID: 8382725 [TBL] [Abstract][Full Text] [Related]
10. Construction of four double gene substitution human x bovine rotavirus reassortant vaccine candidates: each bears two outer capsid human rotavirus genes, one encoding P serotype 1A and the other encoding G serotype 1, 2, 3, or 4 specificity. Hoshino Y; Jones RW; Chanock RM; Kapikian AZ J Med Virol; 1997 Apr; 51(4):319-25. PubMed ID: 9093947 [TBL] [Abstract][Full Text] [Related]
11. Horizontal transmission of rhesus monkey rotavirus-based quadrivalent vaccine during a phase 3 clinical trial in Caracas, Venezuela. Hoshino Y; Wagner M; Yan XY; Perez-Schael I; Kapikian AZ J Infect Dis; 2003 Mar; 187(5):791-800. PubMed ID: 12599053 [TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants. Clements-Mann ML; Dudas R; Hoshino Y; Nehring P; Sperber E; Wagner M; Stephens I; Karron R; Deforest A; Kapikian AZ Vaccine; 2001 Sep; 19(32):4676-84. PubMed ID: 11535316 [TBL] [Abstract][Full Text] [Related]
13. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein. Gil MT; de Souza CO; Asensi M; Buesa J Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999 [TBL] [Abstract][Full Text] [Related]
14. Porcine rotavirus strain Gottfried-based human rotavirus candidate vaccines: construction and characterization. Hoshino Y; Jones RW; Ross J; Kapikian AZ Vaccine; 2005 May; 23(29):3791-9. PubMed ID: 15893616 [TBL] [Abstract][Full Text] [Related]
15. Classification of rotavirus VP4 and VP7 serotypes. Hoshino Y; Kapikian AZ Arch Virol Suppl; 1996; 12():99-111. PubMed ID: 9015107 [TBL] [Abstract][Full Text] [Related]
16. The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. Clark HF; Offit PA; Ellis RW; Eiden JJ; Krah D; Shaw AR; Pichichero M; Treanor JJ; Borian FE; Bell LM; Plotkin SA J Infect Dis; 1996 Sep; 174 Suppl 1():S73-80. PubMed ID: 8752294 [TBL] [Abstract][Full Text] [Related]
17. Identification of group A rotavirus genes associated with virulence of a porcine rotavirus and host range restriction of a human rotavirus in the gnotobiotic piglet model. Hoshino Y; Saif LJ; Kang SY; Sereno MM; Chen WK; Kapikian AZ Virology; 1995 May; 209(1):274-80. PubMed ID: 7747480 [TBL] [Abstract][Full Text] [Related]
18. Construction and characterization of rhesus monkey rotavirus (MMU18006)- or bovine rotavirus (UK)-based serotype G5, G8, G9 or G10 single VP7 gene substitution reassortant candidate vaccines. Hoshino Y; Jones RW; Ross J; Kapikian AZ Vaccine; 2003 Jun; 21(21-22):3003-10. PubMed ID: 12798644 [TBL] [Abstract][Full Text] [Related]
19. Homotypic and heterotypic serum neutralizing antibody response to rotavirus proteins following natural primary infection and reinfection in children. Gorrell RJ; Bishop RF J Med Virol; 1999 Feb; 57(2):204-11. PubMed ID: 9892409 [TBL] [Abstract][Full Text] [Related]
20. A rotavirus vaccine for prevention of severe diarrhoea of infants and young children: development, utilization and withdrawal. Kapikian AZ Novartis Found Symp; 2001; 238():153-71; discussion 171-9. PubMed ID: 11444025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]